SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Windlas Biotech - Quaterly Results

02 Feb 2022 Evaluate
The Total revenue for the quarter ended December 2021 of  Rs. 1175.91 millions remain, more or less, the same.Profit after Tax for the quarter ended December 2021 saw a decline of -32.32% from Rs. 122.86 millions to Rs. 83.15  millions.Operating Profit reported a sharp decline to 148.36 millions from 183.74 millions in the corresponding previous quarter.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202112 202012 % Var 202112 202012 % Var 202112 202012 % Var
Sales 1175.91 1171.95 0.34 1175.91 1171.95 0.34 1175.91 1171.95 0.34
Other Income 17.93 9.88 81.48 17.93 9.88 81.48 17.93 9.88 81.48
PBIDT 148.36 183.74 -19.26 148.36 183.74 -19.26 148.36 183.74 -19.26
Interest 2.11 4.08 -48.28 2.11 4.08 -48.28 2.11 4.08 -48.28
PBDT 146.25 179.66 -18.60 146.25 179.66 -18.60 146.25 179.66 -18.60
Depreciation 31.45 33.41 -5.87 31.45 33.41 -5.87 31.45 33.41 -5.87
PBT 114.80 146.25 -21.50 114.80 146.25 -21.50 114.80 146.25 -21.50
TAX 31.65 23.39 35.31 31.65 23.39 35.31 31.65 23.39 35.31
Deferred Tax 4.12 0.06 6766.67 4.12 0.06 6766.67 4.12 0.06 6766.67
PAT 83.15 122.86 -32.32 83.15 122.86 -32.32 83.15 122.86 -32.32
Equity 108.97 64.11 69.97 108.97 64.11 69.97 108.97 64.11 69.97
PBIDTM(%) 12.62 15.68 -19.53 12.62 15.68 -19.53 12.62 15.68 -19.53

Windlas Biotech Share Price

865.40 -6.35 (-0.73%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×